Announcements Trials
Browse Landscape

Phase

Phase 1 6Phase 2 4Phase 1/2 4Phase NA 1

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 73Plasma cell 60Other hematologic neoplasm 27Genitourinary 6Gynecologic 4Gastrointestinal 4Myeloid 3Thoracic 2Head & Neck 2Tumor-Agnostic 1Sarcoma 1Endocrine 1Dermatologic 1Classical hematology 1CNS 1

Conditions

Pancreatic Neoplasms 2Pancreatic Carcinoma Metastatic 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Gemcitabine 153Oxaliplatin 124Fluorouracil 108Capecitabine 105pembrolizumab 92Bevacizumab 79Leucovorin 76Irinotecan 72Nivolumab 70130-nm albumin-bound paclitaxel 68Paclitaxel 62Cisplatin 62Cetuximab 60Cyclophosphamide 47Albumin-Bound Paclitaxel 45Radiotherapy 39Docetaxel 36durvalumab 33Sorafenib 32Taxes 29Carboplatin 27fludarabine 26tislelizumab 25Drug Therapy 25atezolizumab 23Folfox protocol 23regorafenib 20lenvatinib 19Ipilimumab 19sintilimab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Lenalidomide × Gastrointestinal × Clear all
NCT04257448 2025-09-30

SEPION

GWT-TUD GmbH

Phase 1/2 Completed
75 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01547260 2022-08-22

LENAGEM

Karolinska University Hospital

Phase 1/2 Completed
34 enrolled
Gastrointestinal

Pancreatic Carcinoma Metastatic

NCT01166035 2010-07-20

TEXO

Medical University Innsbruck

Phase 1/2 Unknown
20 enrolled
GastrointestinalHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Colorectal Neoplasms

NCT00179751 2005-11-07

A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the Pancreas

Celgene

Phase 1/2 Terminated
50 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡